One of these molecules is GPNMB whose role in enhancing immunosuppression has been increasingly confirmed in malignancy,14, 21 such as melanoma,22 breast cancer,23 glioma,24 and gastric cancer,25 which may offer an attractive target for cancer immunotherapy.26 This evidence concerns the gene GPNMB and breast cancer.